Compare $EIKN vs $GALT | Chartloom

Compare

$EIKN vs $GALT

Eikon Therapeutics Inc · Galectin Therapeutics Inc

EIKN

Eikon Therapeutics Inc

GALT

Galectin Therapeutics Inc

Compare $EIKN vs $GALT

Comparing Eikon Therapeutics Inc and Galectin Therapeutics Inc

EIKNEikon Therapeutics Inc

GALTGalectin Therapeutics Inc

EIKNEikon Therapeutics Inc

Market cap

$404M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-50.2%

52W performance

-50.2%

FCF yield

-96.6%

GALTGalectin Therapeutics Inc

Market cap

$259M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-2.7%

52W performance

-16.9%

FCF yield

-6.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

EIKN

GALT

Detailed metrics comparison

EIKN

Eikon Therapeutics Inc

GALT

Galectin Therapeutics Inc

Market Cap

EIKN$404M

GALT$259M

Enterprise Value

EIKN$262M

GALT$384M

Price

EIKN$7.47

GALT$3.94

P/E Ratio

EIKNN/A

GALTN/A

P/S Ratio

EIKN0.00x

GALT0.00x

EV/Sales

EIKN0.00x

GALT0.00x

EV/EBITDA

EIKN0.00x

GALT0.00x

P/B Ratio

EIKN0.85x

GALT150.12x

P/FCF Ratio

EIKNN/A

GALTN/A

EV/FCF

EIKN-0.67x

GALT-24.16x

PEG Ratio

EIKN0.00x

GALTN/A

Forward P/E (NTM)

EIKNN/A

GALTN/A

Forward P/S (NTM)

EIKNN/A

GALTN/A

Revenue (TTM)

EIKN$0

GALT$0

Revenue Growth (YoY)

EIKNN/A

GALTN/A

Forward Rev Growth

EIKN436.8%

GALT0.0%

Gross Margin (TTM)

EIKN0.0%

GALT0.0%

Operating Margin (TTM)

EIKN0.0%

GALT0.0%

EBITDA Margin (TTM)

EIKN0.0%

GALT0.0%

Net Margin (TTM)

EIKN0.0%

GALT0.0%

FCF Margin (TTM)

EIKNN/A

GALTN/A

Net Income (TTM)

EIKN$-505M

GALT$-28M

FCF (TTM)

EIKN$-391M

GALT$-16M

EPS (TTM)

EIKN-$9.33

GALT-$0.43

ROE (TTM)

EIKN-11966.0%

GALT-25862.0%

ROA (TTM)

EIKN-6914.0%

GALT-17683.0%

ROIC (TTM)

EIKN-11966.0%

GALT-11607.0%

Cash

EIKN$143M

GALT$13M

Debt

EIKN$0

GALT$138M

Net Cash/Debt

EIKN$143M

GALT$-124M

Current Ratio (TTM)

EIKN9.89x

GALT0.10x

Quick Ratio (TTM)

EIKN9.61x

GALT0.09x

Debt/Equity (TTM)

EIKN0.00x

GALT11.09x

Debt/Assets (TTM)

EIKN0.0%

GALT0.0%

Interest Coverage (TTM)

EIKNN/A

GALTN/A

Net Debt/EBITDA (TTM)

EIKN0.00x

GALT0.00x

Beta

EIKN1.90

GALT0.50

52W Performance

EIKN-50.2%

GALT-16.9%

YTD Performance

EIKN-50.2%

GALT-2.7%

% from 52W High

EIKN-57.1%

GALT-44.7%

% from 52W Low

EIKN6.5%

GALT94.6%

Asset Turnover (TTM)

EIKN0.00x

GALT0.00x

FCF Yield (TTM)

EIKN-96.6%

GALT-6.1%

Earnings Yield (TTM)

EIKN-124.9%

GALT-10.8%

Dividend Yield (TTM)

EIKNN/A

GALTN/A

Rule of 40

EIKN0.0

GALT0.0

EV/GP/RG

EIKNN/A

GALTN/A

Ticker research

View EIKN research View GALT research

Metric	EIKN Eikon Therapeutics Inc	GALT Galectin Therapeutics Inc
Market & Valuation
Market Cap	$404M	$259M
Enterprise Value	$262M	$384M
Price	$7.47	$3.94
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.85x	150.12x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.67x	-24.16x
PEG Ratio	0.00x	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	436.8%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-505M	$-28M
FCF (TTM)	$-391M	$-16M
EPS (TTM)	-$9.33	-$0.43
ROE (TTM)	-11966.0%	-25862.0%
ROA (TTM)	-6914.0%	-17683.0%
ROIC (TTM)	-11966.0%	-11607.0%
Financial Health
Cash	$143M	$13M
Debt	$0	$138M
Net Cash/Debt	$143M	$-124M
Current Ratio (TTM)	9.89x	0.10x
Quick Ratio (TTM)	9.61x	0.09x
Debt/Equity (TTM)	0.00x	11.09x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.90	0.50
52W Performance	-50.2%	-16.9%
YTD Performance	-50.2%	-2.7%
% from 52W High	-57.1%	-44.7%
% from 52W Low	6.5%	94.6%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-96.6%	-6.1%
Earnings Yield (TTM)	-124.9%	-10.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View EIKN research	View GALT research

Valuation

P/S Ratio

EIKN

0.00x

GALT

0.00x

EV/FCF

GALT

-24.16x

EIKN

-0.67x

Growth & revenue

Forward Revenue Growth

EIKN

436.8%

GALT

0.0%

Profitability & performance

Gross Margin

EIKN

0.0%

GALT

0.0%

ROE

EIKN

-11966.0%

GALT

-25862.0%

FCF Yield %

GALT

-6.1%

EIKN

-96.6%

52-Week Performance

GALT

-16.9%

EIKN

-50.2%

Detailed metrics comparison

EIKN

Eikon Therapeutics Inc

GALT

Galectin Therapeutics Inc

Market Cap

EIKN$404M

GALT$259M

Enterprise Value

EIKN$262M

GALT$384M

Price

EIKN$7.47

GALT$3.94

P/E Ratio

EIKNN/A

GALTN/A

P/S Ratio

EIKN0.00x

GALT0.00x

EV/Sales

EIKN0.00x

GALT0.00x

EV/EBITDA

EIKN0.00x

GALT0.00x

P/B Ratio

EIKN0.85x

GALT150.12x

P/FCF Ratio

EIKNN/A

GALTN/A

EV/FCF

EIKN-0.67x

GALT-24.16x

PEG Ratio

EIKN0.00x

GALTN/A

Forward P/E (NTM)

EIKNN/A

GALTN/A

Forward P/S (NTM)

EIKNN/A

GALTN/A

Revenue (TTM)

EIKN$0

GALT$0

Revenue Growth (YoY)

EIKNN/A

GALTN/A

Forward Rev Growth

EIKN436.8%

GALT0.0%

Gross Margin (TTM)

EIKN0.0%

GALT0.0%

Operating Margin (TTM)

EIKN0.0%

GALT0.0%

EBITDA Margin (TTM)

EIKN0.0%

GALT0.0%

Net Margin (TTM)

EIKN0.0%

GALT0.0%

FCF Margin (TTM)

EIKNN/A

GALTN/A

Net Income (TTM)

EIKN$-505M

GALT$-28M

FCF (TTM)

EIKN$-391M

GALT$-16M

EPS (TTM)

EIKN-$9.33

GALT-$0.43

ROE (TTM)

EIKN-11966.0%

GALT-25862.0%

ROA (TTM)

EIKN-6914.0%

GALT-17683.0%

ROIC (TTM)

EIKN-11966.0%

GALT-11607.0%

Cash

EIKN$143M

GALT$13M

Debt

EIKN$0

GALT$138M

Net Cash/Debt

EIKN$143M

GALT$-124M

Current Ratio (TTM)

EIKN9.89x

GALT0.10x

Quick Ratio (TTM)

EIKN9.61x

GALT0.09x

Debt/Equity (TTM)

EIKN0.00x

GALT11.09x

Debt/Assets (TTM)

EIKN0.0%

GALT0.0%

Interest Coverage (TTM)

EIKNN/A

GALTN/A

Net Debt/EBITDA (TTM)

EIKN0.00x

GALT0.00x

Beta

EIKN1.90

GALT0.50

52W Performance

EIKN-50.2%

GALT-16.9%

YTD Performance

EIKN-50.2%

GALT-2.7%

% from 52W High

EIKN-57.1%

GALT-44.7%

% from 52W Low

EIKN6.5%

GALT94.6%

Asset Turnover (TTM)

EIKN0.00x

GALT0.00x

FCF Yield (TTM)

EIKN-96.6%

GALT-6.1%

Earnings Yield (TTM)

EIKN-124.9%

GALT-10.8%

Dividend Yield (TTM)

EIKNN/A

GALTN/A

Rule of 40

EIKN0.0

GALT0.0

EV/GP/RG

EIKNN/A

GALTN/A

Ticker research

View EIKN research View GALT research

Metric	EIKN Eikon Therapeutics Inc	GALT Galectin Therapeutics Inc
Market & Valuation
Market Cap	$404M	$259M
Enterprise Value	$262M	$384M
Price	$7.47	$3.94
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.85x	150.12x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.67x	-24.16x
PEG Ratio	0.00x	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	436.8%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-505M	$-28M
FCF (TTM)	$-391M	$-16M
EPS (TTM)	-$9.33	-$0.43
ROE (TTM)	-11966.0%	-25862.0%
ROA (TTM)	-6914.0%	-17683.0%
ROIC (TTM)	-11966.0%	-11607.0%
Financial Health
Cash	$143M	$13M
Debt	$0	$138M
Net Cash/Debt	$143M	$-124M
Current Ratio (TTM)	9.89x	0.10x
Quick Ratio (TTM)	9.61x	0.09x
Debt/Equity (TTM)	0.00x	11.09x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.90	0.50
52W Performance	-50.2%	-16.9%
YTD Performance	-50.2%	-2.7%
% from 52W High	-57.1%	-44.7%
% from 52W Low	6.5%	94.6%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-96.6%	-6.1%
Earnings Yield (TTM)	-124.9%	-10.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View EIKN research	View GALT research